Archive for February 2021
PET Scans Help Decisions In ER And Breast Cancer
A study has found 100% accuracy for subsequent outcomes with hormonal therapy A small prospective study showed that PET imaging of the progesterone receptor (PgR) response to an estradiol challenge the usual predicted breast cancer response to hormonal therapy. PET with a progestin-analog tracer showed increased PgR levels, indicative of functional estrogen receptors (ERs), in…
Read MoreTelemedicine In ICU Saves Lives— Tele-Intensivist Care Linked To 18% Lower Mortality Over A Decade
A study recently found that in facilities where 24/7 intensivist care was not available, outcomes for patients were better when care was delivered by “tele-intensivists” compared to traditional care models. Within the Cleveland Clinic Health System, patients treated by ICU telemedicine at one of their hospitals were found 18% less likely to die and were…
Read MoreDr. Crosby From Raleigh Radiology: If Others Can Do It, You Can Do It, Too.
Black History Month has been observed since 1926 when the U.S. designated the second week of February to study the history and lives of African Americans. In an effort to remember and celebrate important people and events in the history and present of the African diaspora, Collaborative Imaging ‘s employees have been highlighting their contributions…
Read MorePulmonary Nodules: What Radiologists Should Recommend
Recently, it was acknowledged that radiologists vary widely in whether they recommend follow ups for pulmonary modules. But this is something that deeply needs examination. A new study by Brigham and Women’s Hospital, published Sunday in JACR, claims organizations need to reform this. They remind us that lung cancer is still the deadliest form of…
Read MoreVaccine Shows Effective Against U.K. Variant Of Virus
Phase 2/3 trials show that the AstraZeneca/University of Oxford vaccine are effective against the new U.K. variant. In a pre-print, not yet reviewed by The Lancet, Andrew Pollard, PhD, University of Oxford, claims vaccine efficacy was 74.9% (95% CI 41.6-88.9) after two doses against symptomatic infection from the B.1.1.7 variant. CDC estimates it could be…
Read More